Aquestive therapeutics to report fourth quarter 2023 financial results and recent business highlights on march 5 and host conference call on march 6 at 8:00 a.m. et

Warren, n.j., feb. 21, 2024 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst) (the “company” or “aquestive”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it will report results for the fourth quarter ended december 31, 2023 and provide an update on recent developments in its business after market close on tuesday, march 5, 2024.
AQST Ratings Summary
AQST Quant Ranking